Page last updated: 2024-08-24

prulifloxacin and Health Care Associated Infection

prulifloxacin has been researched along with Health Care Associated Infection in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mirelis, B; Prats, G; Rossi, V; Salvatori, E	1
Mingoia, M; Montanari, MP; Varaldo, PE	1

Reviews

1 review(s) available for prulifloxacin and Health Care Associated Infection

Article	Year
Prulifloxacin: a new antibacterial fluoroquinolone. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Piperazines; Quinolones; Respiratory Tract Infections; Treatment Outcome	2006

Article

Year

Prulifloxacin: a new antibacterial fluoroquinolone.

Expert review of anti-infective therapy, 2006, Volume: 4, Issue:1

Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Piperazines; Quinolones; Respiratory Tract Infections; Treatment Outcome

2006

Other Studies

1 other study(ies) available for prulifloxacin and Health Care Associated Infection

Article	Year
In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12 Topics: Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Dioxolanes; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Italy; Microbial Sensitivity Tests; Piperazines; Quinolones	2001

Article

Year

In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.

Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12

Topics: Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Dioxolanes; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Italy; Microbial Sensitivity Tests; Piperazines; Quinolones

2001